Newlink Genetics reported $78.83M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US USD 251.43M 37.5M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Capricor Therapeutics CAPR:US USD 47.5M 5.12M
Celldex Therapeutics CLDX:US USD 334.6M 33.38M
Eli Lilly And LLY:US USD 17.64B 524.7M
Idera Pharmaceuticals IDRA:US USD 30.07M 4.48M
Intrexon XON:US USD 162.81M 1.81M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Newlink Genetics NLNK:US USD 78.83M 6.16M
Prothena PRTA:US USD 524.56M 3.27M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Vascular Biogenics VBLT:US USD 27.53M 8.16M
YTE INCY:US USD 3.82B 195.27M